BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹22 Cr | ₹9.48 Cr | ₹4.95 Cr | ₹9.73 Cr | ₹-14 Cr |
What is the latest Cash Flow from Operating Activities ratio of BAFNA PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹9.48 Cr |
| Mar2023 | ₹4.95 Cr |
| Mar2022 | ₹9.73 Cr |
| Mar2021 | ₹-14 Cr |
How is Cash Flow from Operating Activities of BAFNA PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹22 Cr | 133.38 | |
| Mar2024 | ₹9.48 Cr | 91.50 | |
| Mar2023 | ₹4.95 Cr | -49.09 | |
| Mar2022 | ₹9.73 Cr | Positive | |
| Mar2021 | ₹-14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹272.4 Cr | 3.6% | -30% | 45.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 3.6% |
-30% |
45.4% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses